SFX by Ex Libris Inc.

Title:	Induction of autoimmune diabetes by oral administration of autoantigen
Source:	Science [0036-8075] Blanas, E yr:1996

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Tsume, Y. "Quantitative evaluation of the gastrointestinal absorption of protein into the blood and lymph circulation." Biological & pharmaceutical bulletin 19.10 (1996): 1332-7.
description	2.	Heath, W R R. "Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction." The Journal of experimental medicine 188.2 (1998): 409-14.
description	3.	Hörig, H. "Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria." The journal of immunology 163.8 (1999): 4434-41.
description	4.	Mayr, A. "GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes." Diabetes 56.6 (2007): 1527-33.
description	5.	Roep BO, B O O. "T-cell responses to autoantigens in IDDM. The search for the Holy Grail." Diabetes 45.9 (1996): 1147-56.
description	6.	"MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity." The journal of immunology. 167.3: 1748-1757.
description	7.	Hansen, Stephanie M. "GAD Autoantibody Affinity in Adult Patients With Latent Autoimmune Diabetes, the Study Participants of a GAD65 Vaccination Trial." Diabetes care 37.6 (2014): 1675-80.
description	8.	Stephanie Krause, S. "IA-2 autoantibody affinity in children at risk for type 1 diabetes." Clinical immunology 145.3 (2012): 224-229.
description	9.	McFarland, H F F. "Complexities in the treatment of autoimmune disease." Science 274.5295 (1996): 2037-8.
description	10.	Iyoda, T. "The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo." The Journal of experimental medicine 195.10 (2002): 1289-1302.
description	11.	Steinman, R. "Features of the dendritic cell lineage." Immunological reviews 234.1 (2010): 5-17.
description	12.	Stryhn, A. "Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanism." European journal of immunology 30.11 (2000): 3089-99.
description	13.	Schlosser, M. "In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk." Diabetologia 48.9 (2005): 1830-2.
description	14.	Elenbaas, B. "Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation." Experimental cell research 264.1 (2001): 169-84.
description	15.	Roep, Bart O O. "The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure." Diabetologia 46.3 (2003): 305-21.
description	16.	Roep, Bart O O. "Islet autoreactive CD8 T-cells in type 1 diabetes: licensed to kill?" Diabetes 57.5 (2008): 1156-1157.
description	17.	Roep, Bart O O. "Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth." Annals of the New York Academy of Sciences 1103 (2007): 1-10.
description	18.	Kline, G H. "B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation." The journal of immunology 162.6 (1999): 3342-3349.
description	19.	Liu, K. "Origin and development of dendritic cells." Immunological reviews 234.1 (2010): 45-54.
description	20.	de Vries, RRP R. "Clinical and preclinical immunology of type 1 diabetes." Netherlands journal of medicine 53.3 (1998): 127-129.